Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. [electronic resource]
- Journal of cardiothoracic and vascular anesthesia Dec 2011
- 987-94 p. digital
Publication Type: Journal Article
1532-8422
10.1053/j.jvca.2011.05.012 doi
Adolescent Aging--physiology Anticoagulants--therapeutic use Blood Coagulation Disorders--diagnosis Blood Loss, Surgical Blood Transfusion--statistics & numerical data Cardiac Surgical Procedures--methods Cardiopulmonary Bypass--methods Child Child, Preschool Echocardiography, Transesophageal Factor VIIa--adverse effects Female Heart Defects, Congenital--surgery Hemostatics Heparin Antagonists--therapeutic use Humans Infant Infant, Newborn Male Off-Label Use Partial Thromboplastin Time Postoperative Hemorrhage--drug therapy Protamines--therapeutic use Prothrombin Time Recombinant Proteins--adverse effects Retrospective Studies Thrombosis--diagnosis